A new combination of antiviral drugs did not improve clinical outcomes in hospitalized patients with severe influenza, warranting further investigation into new therapeutic strategies, according to a recent clinical trial.
A novel combination treatment approach extended survival in mice with pancreatic cancer, demonstrating a potential second-line therapy for patients.
Of the more than 20 episodes of the medical school’s Breakthroughs podcast produced in 2021, the most popular ranged across specialties from gastroenterology to nanotechnology. Listen to the top five episodes of the year and earn Continuing Medical Education credit.
Marijuana use among pregnant and postpartum individuals living with HIV increased from 2007 to 2019, according to a Northwestern Medicine study.
Susan Quaggin, MD, the Charles H. Mayo, MD, Professor and chief of Nephrology and Hypertension in the Department of Medicine, has been elected as a fellow of the National Academy of Inventors (NAI).
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.
Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, which may facilitate the construction of synthetic protein materials.
The underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma, which accounts for 80 percent of all kidney cancers, according to a recent study.
An international team of investigators have released the first-ever study to examine total energy expenditure over the course of the human lifespan, shedding light on human development and aging.
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.